Elevation Oncology (ELEV) PEG Ratio
Market Cap: $22.26M
Avg Volume: 1.52M
Industry: Biotechnology
Sector: Healthcare
PEG Ratio Summary
- Elevation Oncology's trailing twelve month (TTM) PEG ratio is -0.41.
- Elevation Oncology's annual PEG ratio as of today is 0.02.
- Elevation Oncology's quarterly PEG ratio is 0.04.
What is the PEG Ratio?
The PEG ratio (Price/Earnings to Growth ratio) is a valuation metric for determining the relative trade-off between the price of a stock, the earnings generated per share (EPS), and the company's expected growth. A lower PEG ratio suggests that a stock may be undervalued given its earnings performance and growth potential.
How is the PEG Ratio calculated?
The PEG ratio is calculated by dividing the P/E ratio by the annual EPS growth. The formula is:
PEG Ratio = (P/E Ratio) / (EPS Growth Rate)
This helps investors to determine a stock's value while considering the company's earnings growth.
Related Metrics
Other important metrics to assess Elevation Oncology's financial health include:
- P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
- Annual: -0.72
- Quarterly: -0.80
- TTM: -0.50
- P/S Ratio (Price to Sales Ratio) - compares the company's stock price to its revenues:
- Annual: 0.00
- Quarterly: 0.00
- TTM: 0.00
- P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
- Annual: 0.54
- Quarterly: 0.55
- TTM: 0.37
- P/CF Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
- Annual: -0.89
- Quarterly: -3.26
- TTM: -0.61
These metrics provide insights into Elevation Oncology's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
TTM PEG Ratio
-0.41
Annual PEG Ratio
0.02
Quarterly PEG Ratio
0.04
Elevation Oncology Historical PEG Ratio
Historical P/E Ratio
Historical P/S Ratio
Historical P/B Ratio
Historical P/CF Ratio
Elevation Oncology Historical Financial Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | PEG Ratio | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|---|
| 2024 | 0.02 | -0.72 | 0.00 | 0.54 | -0.89 |
| 2023 | 0.01 | -0.40 | 0.00 | 0.33 | -0.33 |
| 2022 | 0.00 | -0.23 | 0.00 | 0.45 | -0.26 |
| 2021 | -0.05 | -4.36 | 0.00 | 0.99 | -4.63 |
| 2020 | -0.08 | -15.74 | 0.00 | -11.78 | -22.10 |
| 2019 | 0.00 | -46.21 | 0.00 | -46.28 | -49.87 |
Related Metrics
Explore detailed financial metrics and analysis for ELEV.